Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenus
-148
-185
229
16
-135
530
Croissance des revenus (H/H)
-159%
-181%
1,331%
-112%
-125%
391%
Coût des ventes
18
22
24
21
1
49
Bénéfice brut
-166
-208
204
-5
-136
480
Vente, Général et Administration
--
0
0
0
1
0
Recherche et développement
--
--
--
--
--
--
Frais d'exploitation
1
0
0
0
1
0
Autres revenus (charges) non opérationnels
--
--
0
0
--
--
Bénéfice avant impôts
-168
-209
204
-6
-137
479
Charge d'impôt sur le revenu
0
0
2
2
3
2
Bénéfice net
-168
-209
201
-8
-141
477
Croissance du bénéfice net
-174%
-204%
-2,613%
-94%
-130%
430%
Actions en circulation (diluées)
461.17
518.98
585.3
644.74
653.07
594.87
Variation des actions (H-H)
-13%
-11%
-9%
-1%
10%
1,019%
EPS (dilué)
-0.36
-0.4
0.34
-0.01
-0.21
0.8
Croissance du EPS
-186%
-218%
-2,627%
-94%
-127%
-53%
Flux de trésorerie libre
0
-1
2
5
-13
0
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
112.16%
112.43%
89.08%
-31.25%
100.74%
90.56%
Marge opérationnelle
113.51%
112.97%
89.08%
-37.5%
101.48%
90.37%
Marge bénéficiaire
113.51%
112.97%
87.77%
-50%
104.44%
90%
Marge du flux de trésorerie libre
0%
0.54%
0.87%
31.25%
9.62%
0%
EBITDA
--
--
--
--
--
--
Marge EBITDA
--
--
--
--
--
--
D&A pour le résultat opérationnel
--
--
--
--
--
--
EBIT
-168
-209
204
-6
-137
479
Marge EBIT
113.51%
112.97%
89.08%
-37.5%
101.48%
90.37%
Taux d'imposition effectif
0%
0%
0.98%
-33.33%
-2.18%
0.41%
Statistiques clés
Clôture préc.
$4.48
Prix d'ouverture
$44.85
Plage de la journée
$3.71 - $3.71
Plage de 52 semaines
$3.71 - $3.71
Volume
19.0K
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
$1.4B
Qu’est-ce que WORLDWIDE HEALTHCARE TRUST ?
Worldwide Healthcare Trust PLC is a GB-based company operating in industry. Worldwide Healthcare Trust PLC is a specialist investment trust. The company invests in the global healthcare sector with the objective of achieving a high level of capital growth. The company invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. The company will not invest more than 15% of the portfolio in any one individual stock at the time of acquisition. The company invests over 50% of the portfolio in larger companies, and 20% of the portfolio in smaller companies. The company may invest 5% of the portfolio, at the time of acquisition, in debt instruments, convertibles and royalty bonds issued by pharmaceutical and biotechnology companies. The company may invest 40% of the portfolio in companies in the healthcare equipment and supplies sector and 30% of the portfolio in companies in the healthcare providers and services sector. Its alternative investment fund manager is Frostrow Capital LLP. OrbiMed Capital LLC is its portfolio manager.